Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells

F. Benyettou, Rachid Rezqui, F. Ravaux, T. Jaber, K. Blumer, M. Jouiad, L. Motte, J. C. Olsen, C. Platas-Iglesias, Mazin Magzoub, Ali Trabolsi

Research output: Contribution to journalArticle

Abstract

We present the synthesis of a silver nanoparticle (AgNP) based drug-delivery system that achieves the simultaneous intracellular delivery of doxorubicin (Dox) and alendronate (Ald) and improves the anticancer therapeutic indices of both drugs. Water, under microwave irradiation, was used as the sole reducing agent in the size-controlled, bisphosphonate-mediated synthesis of stabilized AgNPs. AgNPs were coated with the bisphosphonate Ald, which templated nanoparticle formation and served as a site for drug attachment. The unreacted primary ammonium group of Ald remained free and was subsequently functionalized with either Rhodamine B (RhB), through amide formation, or Dox, through imine formation. The RhB-conjugated NPs (RhB-Ald@AgNPs) were studied in HeLa cell culture. Experiments involving the selective inhibition of cell membrane receptors were monitored by confocal fluorescence microscopy and established that macropinocytosis and clathrin-mediated endocytosis were the main mechanisms of cellular uptake. The imine linker of the Dox-modified nanoparticles (Dox-Ald@AgNPs) was exploited for acid-mediated intracellular release of Dox. We found that Dox-Ald@AgNPs had significantly greater anti-cancer activity in vitro than either Ald or Dox alone. Ald@AgNPs can accommodate the attachment of other drugs as well as targeting agents and therefore constitute a general platform for drug delivery.

Original languageEnglish (US)
Pages (from-to)7237-7245
Number of pages9
JournalJournal of Materials Chemistry B
Volume3
Issue number36
DOIs
StatePublished - Aug 6 2015

Fingerprint

Alendronate
Silver
Doxorubicin
rhodamine B
Cells
Nanoparticles
Microwave irradiation
Confocal microscopy
Fluorescence microscopy
Reducing agents
Cell membranes
Drug delivery
Amides
Cell culture
Imines
Diphosphonates
Acids
Clathrin
Water
Reducing Agents

ASJC Scopus subject areas

  • Chemistry(all)
  • Biomedical Engineering
  • Materials Science(all)

Cite this

Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells. / Benyettou, F.; Rezqui, Rachid; Ravaux, F.; Jaber, T.; Blumer, K.; Jouiad, M.; Motte, L.; Olsen, J. C.; Platas-Iglesias, C.; Magzoub, Mazin; Trabolsi, Ali.

In: Journal of Materials Chemistry B, Vol. 3, No. 36, 06.08.2015, p. 7237-7245.

Research output: Contribution to journalArticle

Benyettou, F, Rezqui, R, Ravaux, F, Jaber, T, Blumer, K, Jouiad, M, Motte, L, Olsen, JC, Platas-Iglesias, C, Magzoub, M & Trabolsi, A 2015, 'Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells' Journal of Materials Chemistry B, vol. 3, no. 36, pp. 7237-7245. https://doi.org/10.1039/c5tb00994d
Benyettou, F. ; Rezqui, Rachid ; Ravaux, F. ; Jaber, T. ; Blumer, K. ; Jouiad, M. ; Motte, L. ; Olsen, J. C. ; Platas-Iglesias, C. ; Magzoub, Mazin ; Trabolsi, Ali. / Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells. In: Journal of Materials Chemistry B. 2015 ; Vol. 3, No. 36. pp. 7237-7245.
@article{faac0deaa7d74816812c610c1018401d,
title = "Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells",
abstract = "We present the synthesis of a silver nanoparticle (AgNP) based drug-delivery system that achieves the simultaneous intracellular delivery of doxorubicin (Dox) and alendronate (Ald) and improves the anticancer therapeutic indices of both drugs. Water, under microwave irradiation, was used as the sole reducing agent in the size-controlled, bisphosphonate-mediated synthesis of stabilized AgNPs. AgNPs were coated with the bisphosphonate Ald, which templated nanoparticle formation and served as a site for drug attachment. The unreacted primary ammonium group of Ald remained free and was subsequently functionalized with either Rhodamine B (RhB), through amide formation, or Dox, through imine formation. The RhB-conjugated NPs (RhB-Ald@AgNPs) were studied in HeLa cell culture. Experiments involving the selective inhibition of cell membrane receptors were monitored by confocal fluorescence microscopy and established that macropinocytosis and clathrin-mediated endocytosis were the main mechanisms of cellular uptake. The imine linker of the Dox-modified nanoparticles (Dox-Ald@AgNPs) was exploited for acid-mediated intracellular release of Dox. We found that Dox-Ald@AgNPs had significantly greater anti-cancer activity in vitro than either Ald or Dox alone. Ald@AgNPs can accommodate the attachment of other drugs as well as targeting agents and therefore constitute a general platform for drug delivery.",
author = "F. Benyettou and Rachid Rezqui and F. Ravaux and T. Jaber and K. Blumer and M. Jouiad and L. Motte and Olsen, {J. C.} and C. Platas-Iglesias and Mazin Magzoub and Ali Trabolsi",
year = "2015",
month = "8",
day = "6",
doi = "10.1039/c5tb00994d",
language = "English (US)",
volume = "3",
pages = "7237--7245",
journal = "Journal of Materials Chemistry B",
issn = "2050-7518",
publisher = "Royal Society of Chemistry",
number = "36",

}

TY - JOUR

T1 - Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells

AU - Benyettou, F.

AU - Rezqui, Rachid

AU - Ravaux, F.

AU - Jaber, T.

AU - Blumer, K.

AU - Jouiad, M.

AU - Motte, L.

AU - Olsen, J. C.

AU - Platas-Iglesias, C.

AU - Magzoub, Mazin

AU - Trabolsi, Ali

PY - 2015/8/6

Y1 - 2015/8/6

N2 - We present the synthesis of a silver nanoparticle (AgNP) based drug-delivery system that achieves the simultaneous intracellular delivery of doxorubicin (Dox) and alendronate (Ald) and improves the anticancer therapeutic indices of both drugs. Water, under microwave irradiation, was used as the sole reducing agent in the size-controlled, bisphosphonate-mediated synthesis of stabilized AgNPs. AgNPs were coated with the bisphosphonate Ald, which templated nanoparticle formation and served as a site for drug attachment. The unreacted primary ammonium group of Ald remained free and was subsequently functionalized with either Rhodamine B (RhB), through amide formation, or Dox, through imine formation. The RhB-conjugated NPs (RhB-Ald@AgNPs) were studied in HeLa cell culture. Experiments involving the selective inhibition of cell membrane receptors were monitored by confocal fluorescence microscopy and established that macropinocytosis and clathrin-mediated endocytosis were the main mechanisms of cellular uptake. The imine linker of the Dox-modified nanoparticles (Dox-Ald@AgNPs) was exploited for acid-mediated intracellular release of Dox. We found that Dox-Ald@AgNPs had significantly greater anti-cancer activity in vitro than either Ald or Dox alone. Ald@AgNPs can accommodate the attachment of other drugs as well as targeting agents and therefore constitute a general platform for drug delivery.

AB - We present the synthesis of a silver nanoparticle (AgNP) based drug-delivery system that achieves the simultaneous intracellular delivery of doxorubicin (Dox) and alendronate (Ald) and improves the anticancer therapeutic indices of both drugs. Water, under microwave irradiation, was used as the sole reducing agent in the size-controlled, bisphosphonate-mediated synthesis of stabilized AgNPs. AgNPs were coated with the bisphosphonate Ald, which templated nanoparticle formation and served as a site for drug attachment. The unreacted primary ammonium group of Ald remained free and was subsequently functionalized with either Rhodamine B (RhB), through amide formation, or Dox, through imine formation. The RhB-conjugated NPs (RhB-Ald@AgNPs) were studied in HeLa cell culture. Experiments involving the selective inhibition of cell membrane receptors were monitored by confocal fluorescence microscopy and established that macropinocytosis and clathrin-mediated endocytosis were the main mechanisms of cellular uptake. The imine linker of the Dox-modified nanoparticles (Dox-Ald@AgNPs) was exploited for acid-mediated intracellular release of Dox. We found that Dox-Ald@AgNPs had significantly greater anti-cancer activity in vitro than either Ald or Dox alone. Ald@AgNPs can accommodate the attachment of other drugs as well as targeting agents and therefore constitute a general platform for drug delivery.

UR - http://www.scopus.com/inward/record.url?scp=84941309376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941309376&partnerID=8YFLogxK

U2 - 10.1039/c5tb00994d

DO - 10.1039/c5tb00994d

M3 - Article

VL - 3

SP - 7237

EP - 7245

JO - Journal of Materials Chemistry B

JF - Journal of Materials Chemistry B

SN - 2050-7518

IS - 36

ER -